Select Publications
Journal articles
1996, 'D-penicillamine causes free radical-dependent inactivation of activator protein-1 DNA binding', Molecular Pharmacology, 50, pp. 501 - 505
,1996, 'Common drug interactions in HIV medicine', MEDICAL JOURNAL OF AUSTRALIA, 164, pp. 605 - 606, http://dx.doi.org/10.5694/j.1326-5377.1996.tb122205.x
,1996, 'Managing HIV. Common drug interactions in HIV medicine.', Med J Aust, 164, pp. 605 - 606, https://www.ncbi.nlm.nih.gov/pubmed/8637465
,1996, 'Experimental pain techniques [2]', British Journal of Clinical Pharmacology, 41, pp. 349 - 350
,1996, 'Naproxen concentration in plasma and synovial fluid and effects on prostanoid concentrations [1]', Journal of Rheumatology, 23, pp. 1826 - 1828
,1996, 'D-Penicillamine causes free-radical-dependent inactivation of activator protein-1 DNA binding', Molecular Pharmacology, pp. 1 - 5
,1996, 'Drug committees - the key to quality use of medicines?', Australian Journal of Hospital Pharmacy, pp. 622 - 623
,1996, 'Effect of single and multiple doses of ibuprofen in chronic spinal pain patients', Analgesia, 2, pp. 93 - 101
,1996, 'Effect of u-opioids morphine and buprenorphine on the development of adjuvant arthritis in rats', Inflammation Research, pp. 557 - 563
,1996, 'Evaluation of the Takeda TM-2420 in the Elderly', Journal of Hypertension, 10, pp. 61 - 61
,1996, 'Experimental pain techniques', British Journal of Clinical Pharmacology, pp. 246 - 246
,1996, 'Hydroxychloroquine relative bioavailability: within subject reproducibility', British Journal of Clinical Pharmacology, pp. 244 - 246
,1996, 'Managing HIV, Quick reference:drug interactions. Common drug interactions in HIV medicine', Medical Journal of Australia, 164, pp. 605 - 606
,1996, 'Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994, A report from the Drug Utilisation Sub-Committee of the Pharmaceutical Benefits Advisory', Medical Journal of Australia, 164, pp. 589 - 592
,1996, 'Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects', British Journal of Clinical Pharmacology, pp. 299 - 304
,1996, 'Potential mechanisms by which nonsteroidal anti-inflammatory drugs elevate blood pressure: the role of endothelin-I', Journal of Hypertension, 10, pp. 257 - 261
,1995, 'Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations', Journal of Rheumatology, 22, pp. 2295 - 2303
,1995, 'OUTCOME MEASURES IN RHEUMATOID-ARTHRITIS CLINICAL-TRIALS - ACKNOWLEDGMENTS', JOURNAL OF RHEUMATOLOGY, 22, pp. 1433 - 1433, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995RG24600046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1995, 'Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos', Proceedings of the National Academy of Sciences of the United States of America, 92, pp. 4497 - 4501, http://dx.doi.org/10.1073/pnas.92.10.4497
,1995, 'TOXICITY OF ANTIRHEUMATIC DRUGS', JOURNAL OF RHEUMATOLOGY, 22, pp. 998 - 999
,1995, 'NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND HIGH BLOOD-PRESSURE - RESPONSE', ANNALS OF INTERNAL MEDICINE, 122, pp. 397 - 397, http://dx.doi.org/10.7326/0003-4819-122-5-199503010-00028
,1995, 'Hazards of low dose methotrexate', Australian and New Zealand Journal of Medicine, 25, pp. 670 - 673, http://dx.doi.org/10.1111/j.1445-5994.1995.tb02851.x
,1995, 'Non-steroidal anti-inflammatory drugs', Medical Journal of Australia, 163, pp. 155 - 158, http://dx.doi.org/10.5694/j.1326-5377.1995.tb127972.x
,1995, 'Nonsteroidal anti-inflammatory drugs and high blood pressure [8]', Annals of Internal Medicine, 122, pp. 397, http://dx.doi.org/10.7326/0003-4819-122-5-199503010-00027
,1995, 'Treatment issues', Bailliere's Clinical Rheumatology, 9, pp. 231 - 245, http://dx.doi.org/10.1016/S0950-3579(05)80158-X
,1995, 'Workshop report - Part 1: Toxicity of antirheumatic drugs', Journal of Rheumatology, 22, pp. 998 - 999
,1995, 'Adverse drug reactions and their measurement in the rheumatic diseases', Journal of Rheumatology, pp. 983 - 988
,1995, 'Clinically Important Drug Interactions.', Drug Safety, 12, pp. 393 - 452
,1995, 'Drug interactions of clinical importance: an updated guide', Drug Safety, 12, pp. 393 - 452
,1995, 'Non-steroidal anti-inflammatory drugs', Medical Journal of Australia, 163, pp. 155 - 158
,1995, 'Pharmacokinetics and pharmacodynamics of naproxen in synovial fluid and plasma', Journal of Rheumatology, pp. 2295 - 2303
,1995, 'The effect of tenoxicam on tolbutamide pharmacokinetics and glucose concentrations in healthy volunteers', International journal of clinical pharmacology, pp. 308 - 310, https://www.ncbi.nlm.nih.gov/pubmed/7655772
,1995, 'Toxicity of antirheumatic drugs. Toxicity Workgroup Leaders.', J Rheumatol, 22, pp. 998 - 999, https://www.ncbi.nlm.nih.gov/pubmed/8587098
,1995, 'Tropical rheumatology. Treatment issues.', Baillieres Clin Rheumatol, 9, pp. 231 - 245, http://dx.doi.org/10.1016/s0950-3579(05)80158-x
,1994, 'Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis', Annals of Internal Medicine, 121, pp. 289 - 300, http://dx.doi.org/10.7326/0003-4819-121-4-199408150-00011
,1994, 'Inflammation '93', Agents and Actions, 41, http://dx.doi.org/10.1007/BF01987616
,1994, 'Evaluation of the accuracy and reproducibility of ambulatory blood pressure monitoring in the very elderly using the Takeda TM-2420', Journal of Human Hypertension, 8, pp. 433 - 439
,1994, 'EFFECT OF HCL CONCENTRATION ON GASTRIC BLOOD-FLOW IN ACUTE ASPIRIN-INDUCED GASTRIC-ULCERS IN THE CAT', GASTROENTEROLOGY, 106, pp. A123 - A123, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994NH90900484&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1994, 'Bioavailability of hydroxychloroquine tablets in patients with rheumatoid arthritis', Rheumatology, 33, pp. 235 - 239, http://dx.doi.org/10.1093/rheumatology/33.3.235
,1994, 'Adverse Interaction Between Warfarin and Indomethacin', Drug Safety, 11, pp. 213 - 214, http://dx.doi.org/10.2165/00002018-199411030-00006
,1994, 'Cannabis and suicide [3]', Medical Journal of Australia, 160, pp. 731, http://dx.doi.org/10.5694/j.1326-5377.1994.tb125924.x
,1994, 'Clinical response to non‐steroidal anti‐inflammatory drugs in urate‐ crystal induced inflammation: a simultaneous study of intersubject and intrasubject variability.', British Journal of Clinical Pharmacology, 38, pp. 341 - 347, http://dx.doi.org/10.1111/j.1365-2125.1994.tb04364.x
,1994, 'Disposition and absorption of hydroxychloroquine enantiomers following a single dose of the racemate', Chirality, 6, pp. 360 - 364, http://dx.doi.org/10.1002/chir.530060421
,1994, 'Meeting report: Asian conference on clinical pharmacology and therapeutics', British Journal of Clinical Pharmacology, 38, pp. 197 - 198
,1994, 'Neither cimetidine nor probenecid affect the pharmacokinetics of tenoxicam in normal volunteers.', British Journal of Clinical Pharmacology, 37, pp. 79 - 81, http://dx.doi.org/10.1111/j.1365-2125.1994.tb04244.x
,1994, 'New Uses for Allopurinol', Drugs, 48, pp. 339 - 344, http://dx.doi.org/10.2165/00003495-199448030-00002
,1994, 'NSAID-related adverse drug interactions with clinical relevance. An update', International Journal of Clinical Pharmacology and Therapeutics, 32, pp. 509 - 532
,1994, 'Pharmacokinetics and pharmacodynamics of hydroxychloroquine enantiomers in patients with rheumatoid arthritis receiving multiple doses of racemate', Chirality, 6, pp. 355 - 359, http://dx.doi.org/10.1002/chir.530060420
,1994, 'Risks and Benefits of Drugs Used in the Management and Prevention of Gout', Drug Safety, 11, pp. 252 - 258, http://dx.doi.org/10.2165/00002018-199411040-00004
,1994, 'The stereoselective disposition of the enantiomers of ibuprofen in blood, blister and synovial fluid.', British Journal of Clinical Pharmacology, 38, pp. 221 - 227, http://dx.doi.org/10.1111/j.1365-2125.1994.tb04345.x
,